Table 1.
Descriptions of the included studies.
| Author/Year/Country |
Age |
Groups |
Diagnostic criteria |
Suicide assessment |
Scores of NOS |
Antidepressant |
||||
|---|---|---|---|---|---|---|---|---|---|---|
| SA | MDD | HC | SA | MDD | HC | |||||
| Shao et al. (2022), China [21] | LLD | 68 | 45 | / | HAMD-17, HAMA, MMSE | BSS, SPS, TSII | 8 | 13/68 | 10/45 | / |
| Hwang et al. (2010), China [22] | LLD | 27 | 43 | 26 | DSM-IV, HAMD-17, MINI, MMSE | MRs | 7 | 0/27 | 0/43 | 0/26 |
| Eileen et al. (2001), the United States [23] | LLD | 20 | 20 | / | HAMD-17, MMSE | MRs | 8 | Not mentioned | Not mentioned | / |
| Wang et al. (2021), China [24] | MAD | 41 | 44 | 52 | DSM-IV，HAMD-17 | BSS, C-SSRS | 9 | 0/41 | 0/44 | 0/52 |
| Zhang et al. (2020), China [25] | MAD | 35 | 38 | 43 | DSM-IV, HAMD-17 | BSS | 8 | 16/35 | 26/38 | 0/43 |
| Yang et al. (2020), China [26] | MAD | 68 | 119 | 103 | DSM-IV, HAMD-17 | NGASR | 8 | 0/68 | 0/119 | 0/103 |
| Wang et al. (2019), China [27] | MAD | 38 | 60 | 60 | DSM-IV, HAMD, YMRS | MRs | 8 | 22/38 | 30/60 | 0/60 |
| Mina et al. (2019), the United States [28] | MAD | 25 | 66 | / | DSM-IV, HAMD-17 | BSS, C-SSRS | 8 | 0/25 | 0/66 | / |
| Lee et al. (2016), Korea [29] | MAD | 19 | 19 | / | DSM-IV, HAMD-17, CGI-S | BSS, BHS, BIS | 7 | 18/19 | 18/19 | / |
| Warren et al. (2015), the United States [30] | MAD | 21 | 53 | 91 | DSM-IV, MADRS, MINI | / | 7 | 0/21 | 0/53 | 0/91 |
| Romain et al. (2015), France [31] | MAD | 24 | 39 | / | DSM-IV, HAMD-17, MINI | MRs | 8 | 19/24 | 30/39 | / |
| Peng et al. (2014), China [32] | MAD | 20 | 18 | 28 | DSM-IV, HAMD-17, DAS, SDS | MRs | 7 | 20/20 | 18/18 | 0/28 |
| Wagner et al. (2012), Germany [33] | MAD | 15 | 15 | 30 | DSM-IV, HAMD-17, MINI | BDI | 8 | 0/15 | 0/15 | 0/30 |
| Monku et al. (2007), the United States [34] | MAD | 7 | 10 | 17 | DSM-IV, HAMD-17 | MRs | 8 | 0/7 | 0/10 | 0/17 |
| Liu et al. (2021), China [35] | AOD | 37 | 23 | / | ICD-10 | BSS | 8 | 0/37 | 0/23 | / |
| Anthony et al. (2021), France [36] | AOD | 28 | 34 | 30 | DSM-IV | BDI, SHQ | 7 | 14/28 | 21/34 | 0/30 |
| Lisa et al. (2015), the United States [37] | AOD | 28 | 31 | 41 | DSM-IV | SIQ, C-SSRS, BDI, SCARED | 9 | 0/28 | 0/31 | 0/41 |
BDI: Beck Depression Inventory; BHS: the Beck Hopelessness Scale; BIS: the Barratt Impulsivity Scale; BSS: the Beck Scale for Suicidal Ideation; CGI-S: the Clinical Global Impression-Severity scale; C-SSRS: Columbia-suicide severity rating scale; DAS: Dysfunctional Attitude Scale; HAMD-17: the 17-item Hamilton Depression Rating Scale; HAMA: Hamilton Anxiety Rating Scale; MADRS: Montgomery Asberg Depression Rating Scale; MINI: Mini-International Neuropsychiatric Interview; MMSE: Mini-Mental State Examination; MRs: Medical Records; NGASR: Nurses' Global Assessment of Suicide Risk Scale; SCARED: the Screen for Childhood Anxiety Related Emotional Disorders; SDS: Self-Rating Depression scale; SHQ: Suicide History Questionnaire (in house questionnaire); SIQ: the Suicidal Ideation Questionnaire; SPS: the SAD PERSONS Scale that assesses suicide potential; TSII: the Triggers of Suicidal Ideation Inventory; YMRS: Young Mania Rating Scale.